poisar

Stocks · News reference

Callan JMB shares are trading lower. The company announced formal approval of blueprints for the planned $16 million intravenous bag manufacturing and distribution facility at the Atlas Complex in Marion, Alabama.

BenzingaBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncNa

    Callan JMB Announces Arrival of Rapid Dose Therapeutics’ QuickStrip™, Resulting in $15 Million in Projected Revenue Over the Next 18 months

    Callan JMB has received a QuickStrip™ oral thin-film production line from Rapid Dose Therapeutics for installation at its Texas facility. The company projects $15 million in revenue over the next 18 months from this new pharmaceutical manufacturing platform, advancing its strategy to expand domestic pharmaceutical manufacturing and healthcare logistics capabilities.